GE HealthCare and Medis team up on precision care in CAD

USA – GE HealthCare has partnered with Medis Medical Imaging to bring advanced precision to the diagnosis and treatment of coronary artery disease (CAD).

The collaboration focuses on expanding access to Medis’ Quantitative Flow Ratio (QFR) technology—an AI-driven, non-invasive solution for assessing coronary physiology.

Medis QFR offers clinicians a faster, image-based alternative to traditional methods like invasive coronary angiography.

This tool helps identify which lesions need treatment and supports more informed decisions during percutaneous coronary intervention (PCI).

As part of the agreement, GE HealthCare will integrate Medis QFR into its interventional cardiology portfolio, centered around the Allia Image Guided System (IGS) platform. This move supports GE’s vision for smarter, more efficient image-guided therapy.

“We’re excited to work with Medis to expand the use of QFR,” said Arnaud Marie, Global GM of Interventional at GE HealthCare.

“QFR represents a major step forward in how we evaluate coronary artery disease. It gives doctors the information they need –quickly and non-invasively – to help patients get the right treatment.”

CAD occurs when the coronary arteries narrow, limiting blood flow to the heart. It’s a leading cause of heart attacks and often requires accurate imaging to guide treatment.

In recent studies, QFR-based assessments helped reduce the rate of myocardial infarction and the need for repeat procedures by improving lesion selection during PCI.

Medis CEO Maya Barley added: “This partnership allows us to bring Medis QFR to more hospitals and doctors. With over a decade of research and development behind it, QFR can make coronary physiology assessment part of everyday care.”